Matthew A. Spear - 28 Jul 2021 Form 4 Insider Report for Poseida Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Jul 2021
Net transactions value
+$26,440
Form type
4
Filing time
30 Jul 2021, 16:29:46 UTC
Previous filing
21 Jun 2021
Next filing
24 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Options Exercise $26,440 +20,000 +93% $1.32 41,485 28 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Options Exercise $0 -20,000 -17% $0.000000 94,861 28 Jul 2021 Common Stock 20,000 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and exercisable.